COVID-19
Cleaning staff excluded from GSK’s £1.5k COVID-19 employee bonus
May 26, 2020Manufacturing and Production COVID-19, GSK, coronavirus, pharma
UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …
WHO stops hydroxychloroquine trial due to safety concerns
May 26, 2020Manufacturing and Production COVID, COVID-19, coronavirus
The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, …
Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines
May 21, 2020Research and Development COVID-19, vaccine coronavirus
“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …
UK begins hydroxychloroquine trial
May 21, 2020Business Services COVID-19, coronavirus, hydroxychloroquine
A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK. The first participants will be enrolled …
Two billion people are at high risk of contracting COVID-19 due to poor sanitation
May 21, 2020Business Services COVID-19, coronavirus, sanitation
About a quarter of the world’s population are at higher risk of catching the COVID-19 coronavirus due to a lack …
Researchers plan to use machine learning methods to estimate the seasonal cycle of COVID-19 in the US
May 21, 2020Business Services COVID-19, coronavirus
Scientists at the Lawrence Berkeley National Laboratory are launching a project to apply machine learning methods to map the severity, …
AstraZeneca targets one billion COVID-19 vaccines by September
May 21, 2020Business Services COVID-19, Vaccine, coronavirus, coronavirus vaccine
AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration …
Pharmafile.com’s weekly COVID-19 news round-up
May 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus
Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic
May 20, 2020Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory
A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
Nanotechnology could be used to assess mortality risk in COVID-19 patients
May 20, 2020Research and Development COVID-19, coronavirus, nanotechnology
Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …
Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS
May 20, 2020Research and Development COVID-19, Diabetics, coronavirus, diabetes
People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope
May 19, 2020Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma
Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …
AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine
May 19, 2020Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma
AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …
US threatens to permanently cut off WHO funding
May 19, 2020Manufacturing and Production COVID-19, Trump, coronavirus
The US has threatened to permanently cut off funding to the World Health Organization if they do not take proposed …
Trump signs deal with generics company Phlow Corp to help shift drug manufacturing to the US
May 19, 2020Manufacturing and Production APIs, COVID-19, Drugs manufacturing, coronavirus, generics
The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
